Results 1 to 10 of about 6,798 (251)

COVID-19 Induced Cholangiopathy: A Case Report [PDF]

open access: goldCase Reports in Gastroenterology
Introduction: COVID-19, although primarily a respiratory illness, has been linked to complications in multiple organ systems, including the liver.
Bassem Al Hariri   +6 more
doaj   +4 more sources

Diet‐Induced Dysbiosis and Genetic Background Synergize With Cystic Fibrosis Transmembrane Conductance Regulator Deficiency to Promote Cholangiopathy in Mice [PDF]

open access: goldHepatology Communications, 2018
The most typical expression of cystic fibrosis (CF)–related liver disease is a cholangiopathy that can progress to cirrhosis. We aimed to determine the potential impact of environmental and genetic factors on the development of CF‐related cholangiopathy ...
Dominique Debray   +10 more
doaj   +2 more sources

Histological Changes in Portal Cavernoma Cholangiopathy [PDF]

open access: goldDiagnostics, 2023
Introduction: Portal cavernoma cholangiopathy (PCC)’ refers to abnormalities of the extrahepatic and intrahepatic bile ducts in patients with portal hypertension.
Archana Rastogi   +3 more
doaj   +2 more sources

Mixed cholangiopathy with eosinophilic and autoimmune features: a case report [PDF]

open access: yesJournal of Medical Case Reports
Background Eosinophilic cholangitis and autoimmune cholangiopathy are two rare immune-mediated biliary disorders with distinct demographic, clinical, and histopathological features.
Henry Shen   +4 more
doaj   +2 more sources

AIDS Cholangiopathy Secondary to Cytomegalovirus as Possible Unmasking Immune Reconstitution Inflammatory Syndrome in Human Immunodeficiency Virus-Infected Individual: Case Report and Review of the Literature [PDF]

open access: goldCase Reports in Infectious Diseases, 2018
We present the first case report of cytomegalovirus (CMV) cholangiopathy as possible immune reconstitution inflammatory syndrome (IRIS) in a human immunodeficiency virus (HIV)-infected individual, within two months of starting effective HAART.
Moiz Topiwala   +5 more
doaj   +2 more sources

Challenges in the diagnosis and treatment of genetic cholestasis in adultsKeypoints [PDF]

open access: yesJHEP Reports
Summary: Disorders of bile formation and bile flow along the intra- and extrahepatic bile ducts are summarised under the term cholestasis. Clinically, conditions resulting in retention of biliary constituents such as bile acids within hepatocytes (termed
Richard J. Thompson   +3 more
doaj   +2 more sources

The role of miRNAs in the development of cholangiopathies. Part 1

open access: yesZdorovʹe Rebenka, 2023
The role of miRNA in the development of cholangiopathies is given in the scientific review. This article discusses the role of miRNA in primary sclerosing cholangitis and primary biliary cho­langitis.
A.E. Abaturov, V.L. Babуch
doaj   +1 more source

A joint transcriptional regulatory network and protein activity inference analysis identifies clinically associated master regulators for biliary atresia

open access: yesFrontiers in Pediatrics, 2022
Biliary atresia (BA) is a devastating cholangiopathy in neonate. Transcription factors (TFs), a type of master regulators in biological processes and diseases, have been implicated in pathogenesis of BA. However, a global view of TFs and how they link to
Panpan Sun   +10 more
doaj   +1 more source

Current Concepts of Biliary Atresia and Matrix Metalloproteinase-7: A Review of Literature

open access: yesFrontiers in Medicine, 2020
Biliary atresia (BA) is a rare cholangiopathy of infancy in which the bile ducts obliterate, leading to profound cholestasis and liver fibrosis. BA is hypothesized to be caused by a viral insult that leads to over-activation of the immune system ...
Mark Nomden   +4 more
doaj   +1 more source

The role of miRNAs in the development of cholangiopathies. Part 2

open access: yesZdorovʹe Rebenka, 2023
The role of miRNA in the development of cho­langiopathies is considered in the scientific review. This article discusses the role of miRNA in biliary atresia, polycystic liver disease, and cholangiocarcinoma.
A.E. Abaturov, V.L. Babуch
doaj   +2 more sources

Home - About - Disclaimer - Privacy